The scope of the COVID-19 pandemic has brought a new set of requirements to healthcare practice worldwide. Curve-flattening and non-pharmaceutical intervention have now entered the lexicon and reflect healthcare’s broader need to become more scalable and virtualized. Digital technology innovations will not only help address COVID-19’s short-term needs, but will also catalyze the development of virtualized solutions for a range of healthcare conditions for our post-COVID future. How might innovations in non-contact, digitally-driven healthcare be among the most impactful and longest-lasting legacies of the COVID-19 crisis?
Daniel Ramirez, Managing Director LEO Innovation Lab Ventures
Oliver Keown, Director, Intuitive Ventures
Thomas Earnest, Founder, CEO of Savant Health
Shomit Ghose, SCET instructor and industry fellow
Dr. Barbara Alcaraz-Silva, SVP Start Up Banking Life Science
The goal of the Innovation-X Roundtable series is to help industry adapt at this critical time. How can companies innovate to create the biggest impact for industry and society now and in the future? From these initial discussions, will emerge Discovery Projects, where we will leverage the resources of UC Berkeley faculty and students to create innovative solutions with Network members that guide the future of industry.